Michael Dale
Medical · Bradenton, FLNPI 1548588262
Payments from drug & device makers
Across 293 payments — averaging $35.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- AbbVie$932
- Bayer$853
- Amgen$805
- GSK$794
- Lilly USA, LLC$786
- plus $3K from 28 others
What the payments were for
- Food & beverage$10,12098%
- Education$1962%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 46 | $3,276 |
| AbbVie | 33 | $932 |
| Bayer | 33 | $853 |
| Amgen | 23 | $805 |
| GSK | 35 | $794 |
| Lilly USA, LLC | 40 | $786 |
| Novo Nordisk | 12 | $420 |
| Pfizer | 13 | $278 |
| Astellas Pharma US Inc | 3 | $247 |
| Phathom Pharmaceuticals, Inc. | 2 | $230 |
| Exact Sciences | 9 | $213 |
| Medtronic | 1 | $176 |
| Silk Road Medical, Inc. | 1 | $146 |
| Amarin Pharma, Inc. | 7 | $141 |
| Neurocrine Biosciences, Inc. | 1 | $127 |
| Mayne Pharma Commercial LLC | 1 | $122 |
| Boehringer Ingelheim | 7 | $117 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $113 |
| Biohaven Pharmaceuticals, Inc. | 1 | $93 |
| Abbott | 5 | $77 |
| Merck | 3 | $61 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $51 |
| Boston Scientific | 2 | $39 |
| Inogen, Inc. | 1 | $33 |
| IBSA Pharma Inc. | 2 | $32 |
| Organon | 1 | $29 |
| Dexcom, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Philips North America LLC | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$927
- AIRSUPRA$741
- BREZTRI$721
- Repatha$350
- LOKELMA$247
- ZEPBOUND$244
- AREXVY$241
- VOQUEZNA$230
- INTELLIS ADAPTIVESTIM$176
- ENROUTE Transcarotid Stent$146
- ENROUTE Transcarotid Neuroprotection System$146
- Kerendia$140
- INGREZZA$127
- TRELEGY ELLIPTA$125
- Veozah$125
- UBRELVY$124
- BIJUVA$122
- VRAYLAR$121
- RYBELSUS$118
- LifeVest$113
How this compares
$10,316 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 32 | $44,240 |
| FarxigaDapagliflozin Propanediol | 31 | $39,176 |
| EliquisApixaban | 24 | $24,268 |
| OzempicSemaglutide | 12 | $12,532 |
| XareltoRivaroxaban | 17 | $9,954 |
| Ezetimibe | 130 | $2,442 |
| Atorvastatin Calcium | 171 | $1,524 |
| PaxlovidNirmatrelvir/Ritonavir | 24 | $1,429 |
| Rosuvastatin Calcium | 133 | $1,388 |
| Levothyroxine Sodium | 101 | $1,105 |
| Colchicine | 14 | $898 |
| Losartan Potassium | 134 | $856 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $778 |
| Metoprolol Succinate | 56 | $775 |
| Amlodipine Besylate | 92 | $671 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $786 | $44,24032 claims |
| AstraZenecaFarxiga | $3,276 | $39,17631 claims |
| PfizerEliquis, Paxlovid | $278 | $25,69848 claims |
| Novo NordiskOzempic | $420 | $12,53212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,031 medical providers in Florida.
Other medical in Bradenton
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.